Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 2 Phase NA 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 2 Prostatic Neoplasms 1 Glioblastoma 1 Carcinoma, Lobular 1

Interventions

Temozolomide 107 Radiotherapy 60 Radiation 28 Bevacizumab 19 Magnetic Resonance Spectroscopy 16 Nivolumab 15 Surgical Procedures, Operative 12 Irinotecan 11 Cyclophosphamide 10 Specimen Handling 9 Chemotherapy, Adjuvant 9 Radiotherapy, Intensity-Modulated 8 Radiosurgery 8 O(6)-benzylguanine 8 Carmustine 8 poly ICLC 7 pembrolizumab 7 motexafin gadolinium 7 fludarabine 7 Leukapheresis 7 Flucytosine 7 sargramostim 6 Radiotherapy, Conformal 6 Erlotinib Hydrochloride 6 Lomustine 5 Ipilimumab 5 Imiquimod 5 Imatinib Mesylate 5 Hydroxyurea 5 Granulocyte-Macrophage Colony-Stimulating Factor 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Glioblastoma × fluciclovine F-18 × Clear all

NCT03990285 2021-12-22

Axumin

Abramson Cancer Center at Penn Medicine

Phase 1 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡